The Retinoblastoma Protein Acts as a Transcriptional Coactivator Required for Osteogenic Differentiation
Open accessThe DOI matches its Crossref record; 69 of the 74 references it cites were found in a registry or an index.
Abstract
The incidence of osteosarcoma is increased 500-fold in patients who inherit mutations in the RB gene. To understand why the retinoblastoma protein (pRb) is specifically targeted in osteosarcoma, we studied its function in osteogenesis. Loss of pRb but not p107 or p130 blocks late osteoblast differentiation. pRb physically interacts with the osteoblast transcription factor, CBFA1, and associates with osteoblast-specific promoters in vivo in a CBFA1-dependent fashion. Association of pRb with CBFA1 and promoter sequences results in synergistic transactivation of an osteoblast-specific reporter. This transactivation function is lost in tumor-derived pRb mutants, underscoring a potential role in tumor suppression. Thus, pRb functions as a direct transcriptional coactivator promoting osteoblast differentiation, which may contribute to the targeting of pRb in osteosarcoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“similar observations have been made for osteosarcoma70–72.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [72]
In the citing paper
“some mutant forms of RB from families with low penetrance retinoblastoma were deficient in E2F binding but retained the ability to induce the differentiation of tumour cells.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [72]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206
Firminger, H. I. (1968) · Armed Forces Institute of Pathology eBooks · Cited by 3,044
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W. H., Beddington, R. S. P., Mundlos, S., Olsen, B. R., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80259-7 · Cited by 2,814
Research works printed but not linked: 2
- Gurney, 1995, Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type, Cancer, 75, 2186, 10.1002/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F · doi:10.1002/1097-0142(19950415)75:8<2186::aid-cncr2820750825>3.0.co;2-f
- Xiao, 1997, Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3–E1 preosteoblasts, Mol. Endocrinol., 11, 1103, 10.1210/mend.11.8.9955 · doi:10.1210/mend.11.8.9955 · Paper page
Cited by
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
“, 2002), raising the possibility that RB contributes to gene repression only under certain conditions, such as when cells differentiate or become senescent (Sellers et al., 1998; Lipinski and Jacks, 1999; Thomas et al., 2001).”
BackgroundSibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158
Building strong bones: molecular regulation of the osteoblast lineage
Long, F. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3254 · Cited by 1,141
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
“This suggests that retention of the ability to induce differentiation might be sufficient to prevent fully penetrant retinoblastoma, and similar observations have been made for osteosarcom”
ResultAdipogenesis: From Stem Cell to Adipocyte
Tang, Q. Q., & Lane, M. D. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052110-115718 · Cited by 902
Metadata
- Authors
- Thomas, D. M., Carty, S. A., Piscopo, D. M., Lee, J.-S., Wang, W.-F., Forrester, W. C., & Hinds, P. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Hinds, Philip W
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2001-08
- Volume
- 8
- Issue
- 2
- Pages
- 303-316
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2090807626
- Cited by
- 361
- References
- 74
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 5 · 2015: 11 · 2014: 19 · 2013: 12 · 2012: 30
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4368 d)
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- retinoblastoma protein, transcriptional coactivator, osteogenic differentiation, osteosarcoma, Runx2, transcriptional activation, tumor suppression, p107, p130
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Humans, Neoplasm Proteins, Neoplasms, Oncogene Proteins, Viral, Osteoblasts, Osteogenesis, Promoter Regions, Genetic, Protein Binding, Recombinant Fusion Proteins, Recombinant Proteins, Osteosarcoma, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Osteocalcin, Retinoblastoma Protein, Genes, Retinoblastoma, Transforming Growth Factor beta, Mutagenesis, Site-Directed, Genes, Reporter, Mice, Knockout, Bone Morphogenetic Proteins, Reverse Transcriptase Polymerase Chain Reaction, Core Binding Factor Alpha 1 Subunit, Papillomavirus E7 Proteins, Mice, Bone Morphogenetic Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Retinoblastoma Protein Acts as a Transcriptional Coactivator Required for Osteogenic Differentiation. https://app.cochat.ai/papers/10.1016/s1097-2765(01)00327-6
- The paper
- Thomas, D. M., Carty, S. A., Piscopo, D. M., Lee, J.-S., Wang, W.-F., Forrester, W. C., & Hinds, P. W. (2001). The Retinoblastoma Protein Acts as a Transcriptional Coactivator Required for Osteogenic Differentiation. Molecular Cell. https://doi.org/10.1016/s1097-2765(01)00327-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.